Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus.
Lactose intolerance, characterized by a decrease in host lactase expression, affects approximately 75% of the world population. Galacto-oligosaccharides (GOS) are prebiotics that have been shown to alleviate symptoms of lactose intolerance and to modulate the intestinal microbiota, promoting the growth of beneficial microorganisms. We hypothesized that mechanisms of GOS utilization by intestinal bacteria are variable, impacting efficacy and response, with differences occurring at the strain level. This study aimed to determine the mechanisms by which human-derived Lactobacillus rhamnosus strains metabolize GOS. Genomic comparisons between strains revealed differences in carbohydrate utilization components, including transporters, enzymes for degradation, and transcriptional regulation, despite a high overall sequence identity (>95%) between strains. Physiological and transcriptomics analyses showed distinct differences in carbohydrate metabolism profiles and GOS utilization between strains. A putative operon responsible for GOS utilization was identified and characterized by genetic disruption of the 6-phospho-β-galactosidase, which had a critical role in GOS utilization. Our findings highlight the importance of strain-specific bacterial metabolism in the selection of probiotics and synbiotics to alleviate symptoms of gastrointestinal disorders including lactose intolerance.
['Arnold|Jason W|JW|', 'Simpson|Joshua B|JB|', 'Roach|Jeffery|J|', 'Bruno-Barcena|Jose M|JM|', 'Azcarate-Peril|M Andrea|MA|0000-0003-0325-1289']
D000069196:Gastrointestinal Microbiome D006026:Glycoside Hydrolases D006801:Humans D052201:Lactobacillus rhamnosus D007787:Lactose Intolerance D009844:Oligosaccharides D056692:Prebiotics
prebiotics for lactose intolerance galacto-oligosaccharides Lactobacillus probiotics β-galactosidases